[1]胡鸣旭,刘莉.黄芪甲苷对心力衰竭大鼠心肌细胞凋亡的影响[J].中国中医药信息杂志,2014,21(1):40-42.[doi:10.3969/j.issn.1005-5304.2014.01.013]
 HU Ming-xu,LIU Li.Effect of Astragaloside on Cardiomyocyte Apoptosis of Heart Failure Rats[J].zhongguo zhongyiyao xinxi zazhi,2014,21(1):40-42.[doi:10.3969/j.issn.1005-5304.2014.01.013]
点击复制

黄芪甲苷对心力衰竭大鼠心肌细胞凋亡的影响

参考文献/References:

[1] Braunwald E, Bristow MR. Congestive heart failure:fifty years of progress[J]. Circulation,2000,102(20 Suppl4):Ⅳ14-Ⅳ23.

[2] Hugel S, Horn M, Remkes H, et al. Preservation of cardiac function and energy reserve by the angiotensin converting enzyme inhibitor quinapril during post-myocardial infarction remodeling in the rat[J]. J Cardiovasc Magn Reson,2001,3(3):215-225.

[3] 孙锴,王克强,葛均波,等.线粒体是防治心力衰竭的重要靶点[J].中华心血管病杂志,2008,36(9):854-859.

[4] 王秋宁,王洪新,杨育红.黄芪甲苷对异丙肾上腺素诱导的乳大鼠心肌细胞肥大的保护作用[J].中国药理学与毒理学杂志,2011,25(1):29-33.

[5] 郑培黎,戴建亚,符卫平,等.黄芪甲苷对急性心衰犬血流动力学的影响[J].中国药理学通报,2005,2(1):1534-1535.

[6] Devika PT, Stanely Mainzen Prince P. Protective effect of (-)- epigallocatechin-gallate(EGCG) on lipid peroxidemetabolism in isoproterenol induced myocardial in farction in male Wistar rats:a histopathological study[J]. Biomed Pharmacother,2008,62(10):701-708.

[7] Katoh H, Nishigaki N, Hayashi H. Diazoxide opens the mitoehondrial permeability transition pore and alters Ca2+ transients in rat ventficular myocytes[J]. Circulation,2002, 105(22):2666-2671.

[8] 郑霁,张西联,周军利,等.微管解聚与心肌细胞缺氧性损害的实验研究[J].第三军医大学学报,2006,28(7):617-620.

[9] Wang Z, Tang X, Li Y, et al. 20-Hydroxyeicosa-tetraenoic acid inhibits the apoptotic responses in-pulmonary artery smooth muscle cells[J]. Eur J Pharmacol,2008,588(1):9-17.

[10] Ogami M, Ikura Y, Ohsawa M, et al. Telomere shortening in human coronary artery diseases[J]. Arterioscler Thromb Vasular Biol, 2004,24:546-549.

[11] Haendeler J. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage[J]. Arterioscler Thromb Vasular Biol,2009,29:929-935.

[12] Guamieri C, Finelli C, Zini M, et al. Effects of trimetazidine on the calcium transport and oxidative phosphorylation of isolated rat heart mitochondria[J]. Basic Res Cardiol,1997,92:90.

[13] Sonia A, Chierchia SL, Margonato V, et al. Effects of trimetazidine on metabolic and functional recovery of post ischemic rat hearts[J]. Cardiovasc Drugs Ther,1998,12:543.

[14] Granger MP, Wright WE, Shay JW. Telomerase in cancer and aging[J]. Crit Rev Onco Hematol,2002,41(1):29-34.

[15] 王旭慧,朱亮,陈红.黄芪甲苷对正常大鼠离体血管功能的影响[J].中国药理学通报,2006,22(11):1319.

[16] 张晶,王洪新,宋莹,等.黄芪甲苷抑制大鼠心肌肥厚及改善心肌能量代谢的作用观察[J].中成药,2012,34(5):924-928.

相似文献/References:

[1]史磊,李永吉,孙凌,等.高效液相色谱-蒸发光散射检测法测定苦瓜降糖丸中黄芪甲苷的含量[J].中国中医药信息杂志,2010,17(10):45.[doi:10.3969/j.issn.1005-5304.2010.10.019]
 SHI Lei,LI Yong-ji,SUN Ling,et al.HPLC-ELSD Determination of Astragaloside Ⅳ in Kuguajiangtang Wan[J].zhongguo zhongyiyao xinxi zazhi,2010,17(1):45.[doi:10.3969/j.issn.1005-5304.2010.10.019]
[2]李妍,吴庆淼,朱艳宇.HPLC-ELSD测定醒脑再造胶囊中黄芪甲苷的含量[J].中国中医药信息杂志,2009,16(4):45.
 LI Yan,WU Qing-miao,ZHU Yan-yu.Determination of Astraloside in Xingnao Zaizao Capsules by HPLC-ELSD[J].zhongguo zhongyiyao xinxi zazhi,2009,16(1):45.
[3]王建明,刘相辉,王和平.高效液相色谱-蒸发光散射法测定补肾斑龙片中黄芪甲苷的含量[J].中国中医药信息杂志,2007,14(1):52.
 WANG Jian-ming,LIU Xiang-hui,WANG He-ping.Determination of Content of Astragaloside in Bushenbanlong Tablet by HPLC-ELSD[J].zhongguo zhongyiyao xinxi zazhi,2007,14(1):52.
[4]赵益业,黄春林,林晓忠.心力衰竭的中西医结合治疗探析[J].中国中医药信息杂志,2007,14(2):81.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(1):81.
[5]周海峰,赵林颖,鲁宪凯,等.中西医结合治疗慢性收缩性心力衰竭临床观察[J].中国中医药信息杂志,2009,16(10):63.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(1):63.
[6]侯凤飞,张海鸣,曹杰,等.薄层扫描法测定首清颗粒中黄芪甲苷的含量[J].中国中医药信息杂志,2009,16(11):44.
 HOU Feng-fei,ZHANG Hai-ming,CAO Jie,et al.Determination of Astragaloside Ⅳ in Shouqing Granula by TLC-Scanning[J].zhongguo zhongyiyao xinxi zazhi,2009,16(1):44.
[7]王建明,王岩松,马晓星,等.乳康胶囊TLC鉴别及含量测定[J].中国中医药信息杂志,2008,15(3):49.
 WANG Jian-ming,WANG Yan-song,MA Xiao-xing,et al.Study on the Quality Control of Rukang Capsule[J].zhongguo zhongyiyao xinxi zazhi,2008,15(1):49.
[8]熊汝菊,毛春芹,谈瑄忠.多指标综合评分法优化更年康颗粒醇提工艺[J].中国中医药信息杂志,2008,15(4):61.[doi:1005-5304(2008)04-0061-03]
 XIONG Ru-ju,MAO Chun-qin,TAN Xuan-zhong.Optimization of the Extraction Technology for Gengniankang Granules with the Multiple Guidelines Grading Method[J].zhongguo zhongyiyao xinxi zazhi,2008,15(1):61.[doi:1005-5304(2008)04-0061-03]
[9]胡芳,潘金火,朱和平.正交试验法优选补阳还五胶囊的水提工艺[J].中国中医药信息杂志,2008,15(9):47.
 HU Fang,PAN Jin-huo,ZHU He-ping.Orthogonal Design on the Extraction Process for Capsule of Buyang Huanwu[J].zhongguo zhongyiyao xinxi zazhi,2008,15(1):47.
[10]张宇.新生脉散片治疗射血分数保留的心力衰竭临床观察[J].中国中医药信息杂志,2011,18(5):75.[doi:10.3969/j.issn.1005-5304.2011.05.033]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(1):75.[doi:10.3969/j.issn.1005-5304.2011.05.033]

备注/Memo

基金项目:教育部高等学校博士学科点专项科研基金(20102327110002);黑龙江省中医药科研项目(ZHY12-Z111);黑龙江省科技攻关计划(GC09C404-1)

更新日期/Last Update: